Giant Rectal Fecaloma Treated with Carbonated Soft Drink and Argon Plasma Coagulation.

Q3 Medicine
European journal of case reports in internal medicine Pub Date : 2025-04-16 eCollection Date: 2025-01-01 DOI:10.12890/2025_005280
Philippe Attieh, Karam Karam, Elias Fiani, Ihab I El Hajj
{"title":"Giant Rectal Fecaloma Treated with Carbonated Soft Drink and Argon Plasma Coagulation.","authors":"Philippe Attieh, Karam Karam, Elias Fiani, Ihab I El Hajj","doi":"10.12890/2025_005280","DOIUrl":null,"url":null,"abstract":"<p><p>Constipation is a common gastrointestinal disorder affecting approximately 15% of the population, with a higher prevalence in women and older adults. It can be classified as primary, including functional constipation, pelvic floor dysfunction, and slow transit, or secondary, resulting from neurological, endocrine, metabolic disorders, cancer, or medications. In individuals over 75, constipation ranks as the seventh most common condition in primary care. A severe complication, fecal impaction, occurs more frequently in older adults and accounts for 0.03% of emergency department visits, with the highest risk in those over 85. In Parkinson's disease, constipation is a significant nonmotor symptom affecting up to 63% of patients and may lead to complications such as intestinal obstruction and aspiration pneumonia. We present the case of a 94-year-old male with Parkinson's disease who developed a 5 × 5 cm rectal fecaloma, unresponsive to standard endoscopic fragmentation techniques, including retrieval tools, high-pressure water jets, and polypectomy snares. Carbonated soft drink (Coca-Cola<sup>®</sup>) injection (500 ml) was used to soften the fecaloma, followed by off-label argon plasma coagulation (APC) (30-50W, 2 l/min), which successfully facilitated further fragmentation and near-total removal. This case highlights the potential role of Coca-Cola<sup>®</sup> and APC as adjunctive therapies in managing refractory fecalomas.</p><p><strong>Learning points: </strong>Standard fecaloma fragmentation methods failed necessitating the injection of a carbonated soft drink (Coca-Cola<sup>®</sup>) into the lumen of the fecaloma and pouring its surface with it followed by the off-label use of argon plasma coagulation for full breakdown of the fecaloma.This highlights the importance of Coca-Cola<sup>®</sup> and argon plasma coagulation as adjunctive therapies in managing refractory fecalomas, with further studies needed to propose the mechanism by which these tools can trigger fecalomas breakdown.</p>","PeriodicalId":11908,"journal":{"name":"European journal of case reports in internal medicine","volume":"12 5","pages":"005280"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12061220/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of case reports in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12890/2025_005280","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Constipation is a common gastrointestinal disorder affecting approximately 15% of the population, with a higher prevalence in women and older adults. It can be classified as primary, including functional constipation, pelvic floor dysfunction, and slow transit, or secondary, resulting from neurological, endocrine, metabolic disorders, cancer, or medications. In individuals over 75, constipation ranks as the seventh most common condition in primary care. A severe complication, fecal impaction, occurs more frequently in older adults and accounts for 0.03% of emergency department visits, with the highest risk in those over 85. In Parkinson's disease, constipation is a significant nonmotor symptom affecting up to 63% of patients and may lead to complications such as intestinal obstruction and aspiration pneumonia. We present the case of a 94-year-old male with Parkinson's disease who developed a 5 × 5 cm rectal fecaloma, unresponsive to standard endoscopic fragmentation techniques, including retrieval tools, high-pressure water jets, and polypectomy snares. Carbonated soft drink (Coca-Cola®) injection (500 ml) was used to soften the fecaloma, followed by off-label argon plasma coagulation (APC) (30-50W, 2 l/min), which successfully facilitated further fragmentation and near-total removal. This case highlights the potential role of Coca-Cola® and APC as adjunctive therapies in managing refractory fecalomas.

Learning points: Standard fecaloma fragmentation methods failed necessitating the injection of a carbonated soft drink (Coca-Cola®) into the lumen of the fecaloma and pouring its surface with it followed by the off-label use of argon plasma coagulation for full breakdown of the fecaloma.This highlights the importance of Coca-Cola® and argon plasma coagulation as adjunctive therapies in managing refractory fecalomas, with further studies needed to propose the mechanism by which these tools can trigger fecalomas breakdown.

碳酸饮料加氩等离子凝固治疗直肠巨粪瘤。
便秘是一种常见的胃肠道疾病,约占人口的15%,在女性和老年人中患病率更高。可分为原发性便秘,包括功能性便秘、盆底功能障碍和传输缓慢,或继发性便秘,由神经、内分泌、代谢紊乱、癌症或药物引起。在75岁以上的人群中,便秘在初级保健中排名第七。一种严重的并发症,粪便嵌塞,在老年人中更常见,占急诊就诊的0.03%,在85岁以上的人群中风险最高。在帕金森病中,便秘是影响多达63%患者的重要非运动症状,并可能导致肠梗阻和吸入性肺炎等并发症。我们报告一名94岁男性帕金森病患者的病例,他发生了一个5 × 5厘米的直肠粪瘤,对标准的内镜碎片化技术无反应,包括取出工具,高压水射流和息肉切除术陷阱。使用碳酸软饮料(Coca-Cola®)注射液(500 ml)软化粪瘤,然后进行超说明书氩等离子凝固(APC) (30-50W, 2 l/min),成功地促进了进一步破碎和几乎完全去除。本病例强调了Coca-Cola®和APC作为治疗难治性粪瘤的辅助疗法的潜在作用。学习要点:标准的粪瘤破碎方法失败,需要将碳酸软饮料(可口可乐®)注射到粪瘤的管腔中,并将其倒入其表面,然后使用超出标签的氩气等离子凝固来完全分解粪瘤。这突出了可口可乐®和氩气等离子凝固作为治疗难治性粪肿的辅助疗法的重要性,需要进一步的研究提出这些工具触发粪肿破裂的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
166
审稿时长
8 weeks
期刊介绍: The European Journal of Case Reports in Internal Medicine is an official journal of the European Federation of Internal Medicine (EFIM), representing 35 national societies from 33 European countries. The Journal''s mission is to promote the best medical practice and innovation in the field of acute and general medicine. It also provides a forum for internal medicine doctors where they can share new approaches with the aim of improving diagnostic and clinical skills in this field. EJCRIM welcomes high-quality case reports describing unusual or complex cases that an internist may encounter in everyday practice. The cases should either demonstrate the appropriateness of a diagnostic/therapeutic approach, describe a new procedure or maneuver, or show unusual manifestations of a disease or unexpected reactions. The Journal only accepts and publishes those case reports whose learning points provide new insight and/or contribute to advancing medical knowledge both in terms of diagnostics and therapeutic approaches. Case reports of medical errors, therefore, are also welcome as long as they provide innovative measures on how to prevent them in the current practice (Instructive Errors). The Journal may also consider brief and reasoned reports on issues relevant to the practice of Internal Medicine, as well as Abstracts submitted to the scientific meetings of acknowledged medical societies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信